168 related articles for article (PubMed ID: 11902805)
1. Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy.
el-Swefy SE; Ali SI; Asker ME; Mohamed HE
J Pharm Pharmacol; 2002 Mar; 54(3):391-7. PubMed ID: 11902805
[TBL] [Abstract][Full Text] [Related]
2. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
El-Swefy SE; Asker ME; Ali SI; Mohammed HE
Pharmacol Res; 2002 Mar; 45(3):167-73. PubMed ID: 11884211
[TBL] [Abstract][Full Text] [Related]
3. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
4. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
[TBL] [Abstract][Full Text] [Related]
5. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid.
Fernández-Miranda C; Gómez P; Díaz-Rubio P; Estenoz J; Carillo JL; Andrés A; Morales JM
Clin Transplant; 2000 Apr; 14(2):110-4. PubMed ID: 10770414
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
Shehata M; Kamel MA
Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12.
Ducloux D; Aboubakr A; Motte G; Toubin G; Fournier V; Chalopin JM; Drüeke T; Massy ZA
Nephrol Dial Transplant; 2002 May; 17(5):865-70. PubMed ID: 11981075
[TBL] [Abstract][Full Text] [Related]
8. Variations in the lipid profile of patients with chronic renal failure, treated with folic acid.
de Gómez Dumm NT; Giammona AM; Touceda LA
Int J Vitam Nutr Res; 2003 May; 73(3):215-20. PubMed ID: 12847999
[TBL] [Abstract][Full Text] [Related]
9. Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects.
Holven KB; Holm T; Aukrust P; Christensen B; Kjekshus J; Andreassen AK; Gullestad L; Hagve TA; Svilaas A; Ose L; Nenseter MS
Am J Med; 2001 May; 110(7):536-42. PubMed ID: 11343667
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
11. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid.
Chiarello PG; Vannucchi MT; Moysés Neto M; Vannucchi H
Int J Vitam Nutr Res; 2003 Nov; 73(6):431-8. PubMed ID: 14743547
[TBL] [Abstract][Full Text] [Related]
13. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
14. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations.
Arnadottir M; Gudnason V; Hultberg B
Nephrol Dial Transplant; 2000 Apr; 15(4):524-8. PubMed ID: 10727548
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of hyperhomocysteinaemia in patients with thrombophilia.
O'Donnell J; Perry DJ
Expert Opin Pharmacother; 2002 Nov; 3(11):1591-8. PubMed ID: 12437493
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification.
Selhub J; Jacques PF; Bostom AG; Wilson PW; Rosenberg IH
Public Health Rev; 2000; 28(1-4):117-45. PubMed ID: 11411265
[TBL] [Abstract][Full Text] [Related]
17. Influence of folic acid on plasma homocysteine levels & arterial endothelial function in patients with unstable angina.
Guo H; Chi J; Xing Y; Wang P
Indian J Med Res; 2009 Mar; 129(3):279-84. PubMed ID: 19491420
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
[TBL] [Abstract][Full Text] [Related]
19. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease.
Guo H; Lee JD; Ueda T; Cheng J; Shan J; Wang J
Indian J Med Res; 2004 Jan; 119(1):33-7. PubMed ID: 14997992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
